Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gadolinium Texaphyrin
2. Gadolinium Texaphyrin Complex
3. Gd(iii) Texaphyrin
4. Motexafin Gadolinium
5. Pci-0120
6. Xcytrin
1. Motexafin Gadolinium
2. Xcytrin
3. Gadolinium Texaphyrin
4. 246252-06-2
5. 156436-89-4
6. Pci-0120
7. Acetic Acid;3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium
8. Api-gp 3; Gd-tex; Gadolinium Texaphyrin; Gd Texaphyrin; Pci 0120; Xcytrin
9. 3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium(3+);diacetate
10. Gadolinium Diacetate (1z,7z,12e,20e)-4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-10,23-dimethyl-13,20,25,26,27-pentaazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaen-27-ide
11. Gdt2b2
12. Mgd
13. Dtxsid4037083
| Molecular Weight | 1150.4 g/mol |
|---|---|
| Molecular Formula | C52H74GdN5O14- |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 28 |
| Exact Mass | 1150.44734 g/mol |
| Monoisotopic Mass | 1150.44734 g/mol |
| Topological Polar Surface Area | 239 Ų |
| Heavy Atom Count | 72 |
| Formal Charge | -1 |
| Complexity | 2080 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Photosensitizing Agents
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)
ABOUT THIS PAGE
A Motexafin Gadolinium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Motexafin Gadolinium, including repackagers and relabelers. The FDA regulates Motexafin Gadolinium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Motexafin Gadolinium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Motexafin Gadolinium supplier is an individual or a company that provides Motexafin Gadolinium active pharmaceutical ingredient (API) or Motexafin Gadolinium finished formulations upon request. The Motexafin Gadolinium suppliers may include Motexafin Gadolinium API manufacturers, exporters, distributors and traders.
click here to find a list of Motexafin Gadolinium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Motexafin Gadolinium DMF (Drug Master File) is a document detailing the whole manufacturing process of Motexafin Gadolinium active pharmaceutical ingredient (API) in detail. Different forms of Motexafin Gadolinium DMFs exist exist since differing nations have different regulations, such as Motexafin Gadolinium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Motexafin Gadolinium DMF submitted to regulatory agencies in the US is known as a USDMF. Motexafin Gadolinium USDMF includes data on Motexafin Gadolinium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Motexafin Gadolinium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Motexafin Gadolinium suppliers with USDMF on PharmaCompass.
Motexafin Gadolinium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Motexafin Gadolinium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Motexafin Gadolinium GMP manufacturer or Motexafin Gadolinium GMP API supplier for your needs.
A Motexafin Gadolinium CoA (Certificate of Analysis) is a formal document that attests to Motexafin Gadolinium's compliance with Motexafin Gadolinium specifications and serves as a tool for batch-level quality control.
Motexafin Gadolinium CoA mostly includes findings from lab analyses of a specific batch. For each Motexafin Gadolinium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Motexafin Gadolinium may be tested according to a variety of international standards, such as European Pharmacopoeia (Motexafin Gadolinium EP), Motexafin Gadolinium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Motexafin Gadolinium USP).
LOOKING FOR A SUPPLIER?
